David Wallace
Executive Editor
Ireland
12+ years of experience
David Wallace 18 Jan 2022
WaveData’s compilation of the fastest-rising UK generics prices in December showed several products across multiple presentations more than doubling their average trade prices to independent pharmacists.
Generics Bulletin
08 Jun 2021
Celltrion has pushed into another new market with its Remsima SC subcutaneous version of infliximab, launching the innovative biosimilar in Canada.
Generics Bulletin
30 Apr 2020
In an exclusive interview with Generics Bulletin, Celltrion Healthcare’s UK commercial director, Matt Eddleston, has set out the firm’s plans to roll out an antibody test and trial two antiviral treatments for COVID-19. Meanwhile, the company’s recently-launched subcutaneous version of biosimilar infliximab, Remsima SC, is helping to free up hospital space in the UK by allowing treatment to be moved out of that setting as the coronavirus pandemic progresses.
Topic Coronavirus
Generics Bulletin
08 Nov 2019
Teva and Celltrion have launched the first biosimilar rituximab in the US, introducing Truxima at a 10% discount to Roche’s Rituxan.
Topic biosimilars strategy
18 May 2022
11 May 2022
11 May 2022
Generics Bulletin
05 May 2022
03 May 2022
13 Apr 2022
18 Mar 2022
Generics Bulletin
17 Mar 2022
Generics Bulletin
10 Mar 2022
10 Mar 2022
09 Mar 2022
17 Dec 2021
Generics Bulletin
13 Dec 2021
16 Nov 2021
10 Nov 2021